129 related articles for article (PubMed ID: 35506353)
1. Three doses of dapsone causing methemoglobinemia in leprosy: A report of two cases.
Sapra D; Singh GK; Bahuguna A; Das P; Gupta A
Dermatol Ther; 2022 Jul; 35(7):e15551. PubMed ID: 35506353
[No Abstract] [Full Text] [Related]
2. Methemoglobinemia and dapsone levels in patients with leprosy.
Vieira JL; Riveira JG; Martins Ade N; Silva JP; Salgado CG
Braz J Infect Dis; 2010; 14(3):319-21. PubMed ID: 20835521
[TBL] [Abstract][Full Text] [Related]
3. The recognition, physiology, and treatment of medication-induced methemoglobinemia: a case report.
Turner MD; Karlis V; Glickman RS
Anesth Prog; 2007; 54(3):115-7. PubMed ID: 17900210
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiologic mechanisms, diagnosis, and management of dapsone-induced methemoglobinemia.
Ashurst JV; Wasson MN; Hauger W; Fritz WT
J Am Osteopath Assoc; 2010 Jan; 110(1):16-20. PubMed ID: 20093649
[TBL] [Abstract][Full Text] [Related]
5. Neonatal methemoglobinemia due to transplacental transfer of dapsone.
Kabra NS; Nanavati RN; Srinivasan G
Indian Pediatr; 1998 Jun; 35(6):553-5. PubMed ID: 10216653
[No Abstract] [Full Text] [Related]
6. Dapsone-induced methemoglobinemia in leprosy patients.
Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
[No Abstract] [Full Text] [Related]
7. Haematological and biochemical alterations in leprosy patients already treated with dapsone and MDT.
Queiroz RH; Melchior JĂșnior E; de Souza AM; Gouveia E; Barbosa JC; de Carvalho D
Pharm Acta Helv; 1997 Sep; 72(4):209-13. PubMed ID: 9372643
[TBL] [Abstract][Full Text] [Related]
8. Dapsone induced methaemoglobinaemia.
Landers D; Bergin C; O'Leary A; Merry C; Keating S; Mulcahy F
Int J STD AIDS; 1996 Oct; 7(6):445-7. PubMed ID: 8940676
[No Abstract] [Full Text] [Related]
9. Challenges in Managing a Lepromatous Leprosy Patient Complicated with Melioidosis Infection, Dapsone-Induced Methemoglobinemia, Hemolytic Anemia, and Lepra Reaction.
Tang ASO; Wong QY; Yeo ST; Ting IPL; Lee JTH; Fam TL; Chew LP; Chua HH; Muniandy P
Am J Case Rep; 2021 May; 22():e931655. PubMed ID: 34038399
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic methaemoglobinaemia and its implications.
Chawla R; Kundra P; Bhattacharya A
Acta Anaesthesiol Scand; 1998 Jul; 42(6):736-8. PubMed ID: 9689284
[TBL] [Abstract][Full Text] [Related]
11. Dapsone agranulocytosis in a leprosy patient.
Hiran S; Pande TK; Pani S; Vishwanathan KA
Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
[TBL] [Abstract][Full Text] [Related]
12. Methemoglobinemia from dapsone therapy for a suspected brown spider bite.
Iserson KV
J Emerg Med; 1985; 3(4):285-8. PubMed ID: 4093581
[TBL] [Abstract][Full Text] [Related]
13. Dapsone: An Update.
Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
[TBL] [Abstract][Full Text] [Related]
14. Dapsone-induced agranulocytosis in a patient of leprosy.
Mishra M; Chhetia R
Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
[No Abstract] [Full Text] [Related]
15. Hepatic and haematological adverse reactions associated with the use of multidrug therapy in leprosy--a five year retrospective study.
Kaluarachchi SI; Fernandopulle BM; Gunawardane BP
Indian J Lepr; 2001; 73(2):121-9. PubMed ID: 11579648
[TBL] [Abstract][Full Text] [Related]
16. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
[TBL] [Abstract][Full Text] [Related]
17. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
Narasimharao P; Pratap DV; Suneetha S
Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
[No Abstract] [Full Text] [Related]
18. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
[TBL] [Abstract][Full Text] [Related]
19. Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy.
Craig J; MacRae C; Melvin RG; Boggild AK
Am J Trop Med Hyg; 2019 May; 100(5):1145-1148. PubMed ID: 30915953
[TBL] [Abstract][Full Text] [Related]
20. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
[No Abstract] [Full Text] [Related]
[Next] [New Search]